ImmunoPrecise Antibodies Ltd. - Common Stock (NQ:IPA)

2.070 UNCHANGED

Last Price Updated: 4:00 PM EDT, Sep 3, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ImmunoPrecise Antibodies Ltd. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Histopathology Data of Preclinical Repeated Dose Toxicity Study and ex vivo Human Tissue Cross-Reactivity (TCR) Analysis Support Safety of IPA’s PolyTope® TATX-03, a Synergistic Antibody Cocktail against SARS‑CoV‑2

July 12, 2022

From ImmunoPrecise Antibodies

Via Business Wire

Immunity Focused Biotherapeutic Developer with a Hybrid of Services and Technology for a Wide Range of Applications: ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA)

July 07, 2022

Via Get News

Topics Artificial Intelligence

‘Baby with the Bathwater’ Biotechs (IPA, NRXP, PRFX, LEXX, LQDI)

June 01, 2022

Via AB Newswire

Stocks That Hit 52-Week Lows On Friday ↗

March 11, 2022

During Friday's session, 198 companies made new 52-week lows. Key Facts About Today's 52-Week Highs And Lows: Alibaba Group Holding (NYSE:BABA) is the largest...

Via Benzinga

ImmunoPrecise's COVID-19 Antibody Cocktail Shows Neutralization Activity Against Omicron ↗

January 31, 2022

Immunoprecise Antibodies Ltd (NASDAQ: IPA) has released preclinical data for the PolyTope TATX-03 COVID-19 antibody cocktail.

Via Benzinga

Small Cap Biotechnology Companies Release Positive Quarterly Results (IPA, AVIR, LQDA, ABSI, APVO)

May 31, 2022

Via AB Newswire

Biotech Recovery Accelerates These Companies Benefit (IPA, SIGA, MNKD, INO, CTIC)

May 25, 2022

Via AB Newswire

IPA’s Subsidiary BioStrand Secures Second VLAIO Research Grant

May 09, 2022

From ImmunoPrecise Antibodies

Via Business Wire

IPA’s Advanced PolyTope® TATX-03, a Multi-Antibody Cocktail, Potently Prevents In Vitro Infection of Cells by the Currently Dominant Omicron Sublineage BA.2, in Addition to all Other Variants of Concern

April 20, 2022

From ImmunoPrecise Antibodies

Via Business Wire

IPA Completes Acquisition of Belgian Technology Companies BioStrand, BioKey, and BioClue – Adding Artificial Intelligence-Driven Analytics to its Antibody Discovery Capabilities and Offerings

April 14, 2022

From ImmunoPrecise Antibodies

Via Business Wire

IPA Announces Agreement to Acquire BioStrand BV – Revolutionizing Biotherapeutics with Methodology to Encode Omics and Power Drug Development with Advanced Artificial Intelligence

March 29, 2022

From ImmunoPrecise Antibodies

Via Business Wire

The Daily Biotech Pulse: Pfizer-BioNTech Apply For Authorization Of 3rd Booster Shot, Sanofi-Seagen Strike Cancer Therapy Pact, Iovance Gets Nod For Cancer Study ↗

March 16, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

ImmunoPrecise Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2022

March 16, 2022

From ImmunoPrecise Antibodies Ltd.

Via Business Wire

Earnings Scheduled For March 16, 2022 ↗

March 16, 2022

Companies Reporting Before The Bell • Ideanomics (NASDAQ:IDEX) is likely to report quarterly loss at $0.05 per share on revenue of $33.20 million. • Tarena...

Via Benzinga

Immunoprecise, Elektrofi To Pursue Low-Volume Injectable Formulation Of IPA's COVID-19 Antibody Cocktail ↗

March 14, 2022

Elektrofi and Immunoprecise Antibodies Ltd (NASDAQ: IPA) have collaborated to explore a high-concentration formulation of IPA's COVID-19 antibody...

Via Benzinga

IPA Selected to Work with Elektrofi on COVID-19 Therapeutic Delivery and Future Pandemic Preparation under SBIR Contract from Defense Health Agency within US Department of Defense

March 14, 2022

From Elektrofi and ImmunoPrecise Antibodies

Via Business Wire

The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings ↗

March 13, 2022

Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments...

Via Benzinga

Immunoprecise's COVID-19 Antibody Cocktail Shows Favorable Safety, Toxicity Profile ↗

March 09, 2022

Immunoprecise Antibodies Ltd (NASDAQ: IPA) has reported preclinical data of PolyTope TATX-03 antibody cocktail therapy against COVID-19. The IND-enabling animal studies did...

Via Benzinga

Immunotherapeutic PolyTope® from ImmunoPrecise (IPA) Potently Neutralizes the SARS-CoV-2 Omicron Variant – Moves Towards FDA/IND-Submission

January 31, 2022

From ImmunoPrecise Antibodies Ltd.

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

February 15, 2022

Tuesday's session saw 95 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The largest company by market cap to set a new 52-...

Via Benzinga

ImmunoPrecise Relocates European Subsidiary to LEED Certified Campus to Continue to Advance its Antibody Research Operations and Environmental Sustainability

January 18, 2022

From ImmunoPrecise Antibodies Ltd.

Via Business Wire

ImmunoPrecise Antibodies Announces Grant of Stock Options

January 17, 2022

From ImmunoPrecise Antibodies Ltd.

Via Business Wire

ImmunoPrecise Antibodies Announces Grant of Stock Options

January 11, 2022

From ImmunoPrecise Antibodies Ltd.

Via Business Wire

ImmunoPrecise Antibodies Announces Grant of Stock Options

January 03, 2022

From ImmunoPrecise Antibodies Ltd.

Via Business Wire

ImmunoPrecise Antibodies and ChemPartner Biologics Announce PolyTope® TATX-03 Antibody Cocktail Manufacturing Collaboration

December 20, 2021

From IMMUNOPRECISE ANTIBODIES LTD.

Via Business Wire

ImmunoPrecise Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2022

December 13, 2021

From ImmunoPrecise Antibodies Ltd.

Via Business Wire

ImmunoPrecise Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2022

December 07, 2021

From ImmunoPrecise Antibodies Ltd.

Via Business Wire

ImmunoPrecise Update on its SARS-CoV-2 PolyTope™ Multi-Antibody Cocktail Development Program

November 30, 2021

From ImmunoPrecise Antibodies Ltd.

Via Business Wire

56 Biggest Movers From Friday ↗

November 29, 2021

Gainers iSpecimen Inc. (NASDAQ: ISPC) climbed 71.7% to settle at $17.51 on Friday. The company recently announced it has been contracted to support new advanced research on...

Via Benzinga

48 Stocks Moving In Friday's Mid-Day Session ↗

November 26, 2021

Gainers Allied Healthcare Products, Inc. (NASDAQ: AHPI) shares jumped 68% to $9.04. Shares of mask and protective apparel companies, including Allied Healthcare Products, traded...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.